CDC/ACIP [to 13 Jul 2019]

CDC/ACIP [to 13 Jul 2019]
http://www.cdc.gov/media/index.html
https://www.cdc.gov/vaccines/acip/index.html
Thursday, July 11, 2019
TRANSCRIPT of July 9, 2019, CDC Vital Signs: Nationwide Outbreak of Acute Flaccid Myelitis—United States, 2018

CDC Lab Research Shows Two Treatments Effective Against DRC Ebola Strain
Tuesday, July 9, 2019
[See DRC – Ebola above for detail]

CDC Telebriefing-New Vital Signs Report – CDC reports on largest acute flaccid myelitis (AFM) outbreak: doctors should recognize symptoms early and report all suspected cases
Tuesday, July 9, 2019

CDC Urges Doctors to Rapidly Recognize and Report AFM Cases
Tuesday, July 9, 2019

MMWR News Synopsis for July 12, 2019
Changes in HIV Preexposure Prophylaxis (PrEP) Awareness and Use Among Men Who Have Sex with Men — 20 Urban Areas, 2014 and 2017
Use of a daily pill for HIV prevention – HIV preexposure prophylaxis or PrEP – has increased but remains too low, particularly among gay and bisexual African American and Latino men. More gay and bisexual men at high risk for HIV are using PrEP. CDC analyzed data from more than 7,800 interviews with gay and bisexual men at high risk for HIV in 20 U.S. cities. The analysis found that reported PrEP use increased from 6% to 35% — and that reported awareness of PrEP increased from 60% to 90% — among the survey participants between 2014 and 2019. Despite those increases, PrEP use remains too low. African American and Latino gay and bisexual men reported lower PrEP awareness and use than white gay and bisexual men. To end the HIV epidemic in the United States, healthcare providers should routinely test their patients for HIV, assess HIV-negative patients for indications of HIV risk, and appropriately prescribe PrEP.

Vital Signs: Surveillance for Acute Flaccid Myelitis — United States, 2018